Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study

PURPOSE: Reactive oxygen species modulator 1 (ROMO1) is a novel protein regulating intracellular reactive oxygen species production. Although increased ROMO1 expression has been associated with poor clinical outcomes in several human malignancies, the clinical implication of this protein in a radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Moonkyoo, Sung, Ji-Youn, Lee, Seung Hyeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790331/
https://www.ncbi.nlm.nih.gov/pubmed/31632076
http://dx.doi.org/10.2147/OTT.S217514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790331/
https://www.ncbi.nlm.nih.gov/pubmed/31632076
http://dx.doi.org/10.2147/OTT.S217514

Ejemplares similares